
Vaibhavi M. | Dec 06, 2025

Ravindra Warang | Jun 23, 2025
Pharmaceutical contract manufacturing in 2026 evolves as CDMOs become strategic partners driving scale, compliance, and innovation.

Explore how mRNA therapeutics are manufactured, from DNA templates to LNP formulation, with key challenges, regulations, and future trends.

Vaccine contract manufacturing in 2026 shifts toward digitalization, regionalization, and strategic CDMO partnerships powering global immunization

Why water stewardship is critical for pharma manufacturing in 2026 and how it impacts global health, supply chains, and community resilience.

India is transitioning from generics dominance to a global biologics and biosimilars leader, shaping the future of advanced therapies.
